Research Analysts’ Weekly Ratings Changes for Bausch Health Cos (BHC)

Several brokerages have updated their recommendations and price targets on shares of Bausch Health Cos (NYSE: BHC) in the last few weeks:

• 8/1/2026 – Bausch Health Cos was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 7/31/2026 – Bausch Health Cos was upgraded by Weiss Ratings from “sell (d-)” to “sell (d)”.
• 7/24/2026 – Bausch Health Cos was downgraded by Zacks Research from “hold” to “strong sell”.
• 7/22/2026 – Bausch Health Cos was upgraded by Jefferies Financial Group Inc. to “hold”.

Insider Activity at Bausch Health Cos

In other news, Director Frank D. Lee sold 24,456 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $5.43, for a total value of $132,796.08. Following the completion of the transaction, the director owned 49,339 shares of the company’s stock, valued at approximately $267,910.77. This trade represents a 33.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 20.67% of the company’s stock.

Bausch Health Cos Inc, formerly known as Valeant Pharmaceuticals International, is a global specialty pharmaceutical company headquartered in Laval, Quebec, Canada. The company operates through two primary segments: Ophthalmology, led by its Bausch + Lomb franchise, and Diversified Brands, which encompasses prescription dermatology, gastrointestinal, neurology and branded pharmaceutical products. Bausch Health develops, manufactures and markets a range of therapeutic and over-the-counter offerings designed to address conditions such as cataracts, dry eye, glaucoma, acne, rosacea, migraine and gastrointestinal disorders.

The Ophthalmology segment under the Bausch + Lomb name provides products for eye health, including prescription drops, contact lens care solutions, intraocular lenses, surgical instruments and diagnostic devices.